CC
CANO

Clearline Capital’s Cano Health, Inc. CANO Stock Holding History

Clearline Capital’s Portfolio CANO Stock Details CANO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-2,014
Closed -$1.75M – 154
2022
Q3 		$1.75M Hold
2,014
– – 0.21% 78
2022
Q2 		$882K Hold
2,014
– – 0.11% 93
2022
Q1 		$1.28M Buy
2,014
+150
+8% +$94.6K 0.15% 87
2021
Q4 		$1.66M Hold
1,864
– – 0.18% 79
2021
Q3 		$2.36M Buy
1,864
+984
+112% +$1.19M 0.22% 74
2021
Q2 		$1.06M Buy
880
+73
+9% +$98.5K 0.16% 88
2021
Q1 		$1.07M Buy
807
+648
+408% +$917K 0.14% 73
2020
Q4 		$213K Buy
+159
New +$182K 0.05% 69

Other funds holding CANO

JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
OCAM
Owl Creek Asset Management New York $1.38B AUM 59.67% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return